Eric Simpson, M.D., notes “there is a critical need for additional treatment options” for patients with moderate to severe atopic dermatitis in a Leo Pharma news release about the efficacy and safety of tralokinumab in treating the condition.

During a presentation at the European Congress of Rheumatology of the European League Against Rheumatism about secukinumab’s long-term use for psoriasis and psoriatic arthritis, Atul Deodhar, M.D., is quoted as saying the drug “was well-tolerated.”

Emily Henkle, Ph.D., M.P.H., and James A. Gaudino, Jr., M.D., M.S., M.P.H., are quoted in an article about the risks and benefits of reopening schools in the fall.

While discussing two Nature studies that describe similar sets of mice neurons in the hypothalamus that induce hibernation, Shaun Morrison, Ph.D., asks “The big question is, are these the same neurons?”

In a story on computer algorithms that can help detect weak spots in tumor molecules, Gordon Mills, M.D., Ph.D., says, “There have been hundreds of algorithms that have failed to truly capture the complexity and heterogeneity of cancer and have not panned out in attempts to move them through to the clinic.”

OHSU is among several Oregon organizations voicing concerns about racism.

In coverage about new guidelines that recommend routinely providing anxiety screening for adolescent girls and women, Heidi D. Nelson, M.D., M.P.H., says “The goal of screening is to increase detection and achieve earlier diagnosis, initiate appropriate treatment, and ultimately improve the health, function and well-being of women and girls.”

A story includes recommendation from Eliza Hayes Bakken, M.D., regarding the use of daycare centers during the pandemic.

Jen-Jane Liu, M.D., discusses screening and treatment options for patients with kidney cancer.

Two studies focused on patients with metastatic castration-resistant prostate cancer, co-authored by Tom Beer, M.D., are highlighted at the American Society for Clinical Oncology 2020 conference